Abstract P1-09-10: Molecular and genetic characterisation of contralateral breast cancers in Northern Ireland: Opportunities for personalised surgery

CG McIlmunn; FJ Bannon; D Fitzpatrick; A Ervine; C Boyd; I Cameron; T Harita; J James; D Gonzalez de Castro; KI Savage; SA McIntosh

doi:10.1158/1538-7445.SABCS18-P1-09-10

Abstract P1-09-10: Molecular and genetic characterisation of contralateral breast cancers in Northern Ireland: Opportunities for personalised surgery

CG McIlmunn, FJ Bannon, D Fitzpatrick, A Ervine, C Boyd, I Cameron, T Harita, J James, D Gonzalez de Castro, KI Savage, SA McIntosh

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	P1-09-10
Journal	Cancer Res
Volume	79
Issue number	4 Supplement
DOIs	https://doi.org/10.1158/1538-7445.SABCS18-P1-09-10
Publication status	Published - 15 Feb 2019

Access to Document

10.1158/1538-7445.SABCS18-P1-09-10Licence: Unspecified

Fingerprint Dive into the research topics of 'Abstract P1-09-10: Molecular and genetic characterisation of contralateral breast cancers in Northern Ireland: Opportunities for personalised surgery'. Together they form a unique fingerprint.

Cite this

McIlmunn, CG., Bannon, FJ., Fitzpatrick, D., Ervine, A., Boyd, C., Cameron, I., Harita, T., James, J., Gonzalez de Castro, D., Savage, KI., & McIntosh, SA. (2019). Abstract P1-09-10: Molecular and genetic characterisation of contralateral breast cancers in Northern Ireland: Opportunities for personalised surgery. Cancer Res, 79(4 Supplement), P1-09-10. https://doi.org/10.1158/1538-7445.SABCS18-P1-09-10

McIlmunn, CG ; Bannon, FJ ; Fitzpatrick, D ; Ervine, A ; Boyd, C ; Cameron, I ; Harita, T ; James, J ; Gonzalez de Castro, D ; Savage, KI ; McIntosh, SA. / Abstract P1-09-10: Molecular and genetic characterisation of contralateral breast cancers in Northern Ireland: Opportunities for personalised surgery. In: Cancer Res. 2019 ; Vol. 79, No. 4 Supplement. pp. P1-09-10.

@article{1cf0441b783f48a9874bd9d780e488ce,

title = "Abstract P1-09-10: Molecular and genetic characterisation of contralateral breast cancers in Northern Ireland: Opportunities for personalised surgery",

author = "CG McIlmunn and FJ Bannon and D Fitzpatrick and A Ervine and C Boyd and I Cameron and T Harita and J James and {Gonzalez de Castro}, D and KI Savage and SA McIntosh",

year = "2019",

month = feb,

day = "15",

doi = "10.1158/1538-7445.SABCS18-P1-09-10",

language = "English",

volume = "79",

pages = "P1--09--10",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "4 Supplement",

}

McIlmunn, CG , Bannon, FJ, Fitzpatrick, D, Ervine, A, Boyd, C, Cameron, I, Harita, T, James, J , Gonzalez de Castro, D , Savage, KI & McIntosh, SA 2019, 'Abstract P1-09-10: Molecular and genetic characterisation of contralateral breast cancers in Northern Ireland: Opportunities for personalised surgery', Cancer Res, vol. 79, no. 4 Supplement, pp. P1-09-10. https://doi.org/10.1158/1538-7445.SABCS18-P1-09-10

Abstract P1-09-10: Molecular and genetic characterisation of contralateral breast cancers in Northern Ireland: Opportunities for personalised surgery. / McIlmunn, CG ; Bannon, FJ; Fitzpatrick, D; Ervine, A; Boyd, C; Cameron, I; Harita, T; James, J ; Gonzalez de Castro, D ; Savage, KI ; McIntosh, SA.

In: Cancer Res, Vol. 79, No. 4 Supplement, 15.02.2019, p. P1-09-10.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Abstract P1-09-10: Molecular and genetic characterisation of contralateral breast cancers in Northern Ireland: Opportunities for personalised surgery

AU - McIlmunn, CG

AU - Bannon, FJ

AU - Fitzpatrick, D

AU - Ervine, A

AU - Boyd, C

AU - Cameron, I

AU - Harita, T

AU - James, J

AU - Gonzalez de Castro, D

AU - Savage, KI

AU - McIntosh, SA

PY - 2019/2/15

Y1 - 2019/2/15

U2 - 10.1158/1538-7445.SABCS18-P1-09-10

DO - 10.1158/1538-7445.SABCS18-P1-09-10

M3 - Meeting abstract

VL - 79

SP - P1-09-10

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 4 Supplement

ER -